Learn about Proleukin (aldesleukin), the first FDA-approved immunotherapy for the treatment of metastatic melanoma.
Interleukin 2 (IL-2) is an interleukin, a type of cytokine signaling molecule in the immune system. It is a protein that regulates the activities of white blood cells ...
Aldesleukin (Proleukin) cancer drug has many side effects and drug interactions. Aldesleukin is prescribed to treat metastatic kidney cancer and melanoma.
Aldesleukin is a cancer medication that interferes with tumor growth. Aldesleukin is used to treat kidney cancer or skin cancer than has spread to other parts of the ...
The National Institutes of Health’s MedLine Plus website is now our go-to source for reliable, timely cancer drug information that meets our standards and patient ...
Aldesleukin injection must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy ...
How Aldesleukin is given: Aldesleukin has been approved for cancer treatment with a high-dose regimen, but it may also be administered in a low-dose form.
Proleukin® (aldesleukin), a human recombinant interleukin-2 product, is a highly purified protein with a molecular weight of approximately 15,300 daltons.
This page contains brief information about aldesleukin and a collection of links to more information about the use of this drug, research results, and ongoing ...
Proleukin ® Interleukin-2 (IL-2) can give the immune system more power to fight metastatic melanoma. There are several therapies for metastatic melanoma.